Contact this trialFirst, we need to learn more about you.
Immunoglobulin Replacement Therapy
TAK-881 for Primary Immunodeficiency
Recruiting2 awardsPhase 3
Macon, Georgia
"This trial aims to determine if TAK-881 is safe for long-term use in adults and children with Primary Immunodeficiency Disorder who completed a previous study. Participants will receive TAK-881 inf
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service